GENELABS TECH INC has a total of 453 patent applications. Its first patent ever was published in 1988. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CANCER RES TECH LTD, SICHUAN KELUN BOTAI BIOMEDICAL CO LTD and PROLIFIX LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 90 | |
#2 | WIPO (World Intellectual Property Organization) | 50 | |
#3 | EPO (European Patent Office) | 46 | |
#4 | Australia | 40 | |
#5 | Canada | 38 | |
#6 | Taiwan | 27 | |
#7 | China | 23 | |
#8 | Brazil | 17 | |
#9 | Republic of Korea | 15 | |
#10 | Israel | 14 | |
#11 | Mexico | 14 | |
#12 | Norway | 12 | |
#13 | South Africa | 12 | |
#14 | Argentina | 11 | |
#15 | Japan | 8 | |
#16 | New Zealand | 7 | |
#17 | Hong Kong | 6 | |
#18 | Peru | 5 | |
#19 | El Salvador | 4 | |
#20 | Uruguay | 4 | |
#21 | African Regional Industrial Property Organization | 2 | |
#22 | Singapore | 2 | |
#23 | Finland | 1 | |
#24 | Ireland | 1 | |
#25 | Morocco | 1 | |
#26 | Malaysia | 1 | |
#27 | Portugal | 1 | |
#28 | Tunisia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Machines | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Sugars | |
#7 | Measuring microorganism processes | |
#8 | Unspecified technologies | |
#9 | Analysing materials | |
#10 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Roberts Christopher Don | 165 |
#2 | Schmitz Franz Ulrich | 76 |
#3 | Dyatkina Natalia B | 75 |
#4 | Griffith Ronald Conrad | 75 |
#5 | Botyanszki Janos | 72 |
#6 | Keicher Jesse D | 68 |
#7 | Shi Dong-Fang | 57 |
#8 | Fry Kirk E | 45 |
#9 | Reyes Gregory R | 43 |
#10 | Kim Jungsuh P | 37 |
Publication | Filing date | Title |
---|---|---|
US2010204265A1 | Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections | |
US2009197880A1 | Anti-viral compounds, compositions, and methods of use | |
TW200927751A | Antiviral compounds | |
WO2009029729A1 | Amino tricyclic-nucleoside compounds, compositions, and methods of use | |
US2009317360A1 | Anti-viral inhibitors and methods of use | |
US2008193411A1 | Anti-viral Compounds | |
US2008181866A1 | Amido Anti-viral Compounds | |
US2008045498A1 | Polycyclic viral inhibitors | |
US2008051384A1 | Antiviral agents | |
BRPI0714346A2 | Antiviral agents | |
BRPI0619733A2 | n- (6-membered aromatic ring) -amido antiviral compounds | |
CN101331125A | N-(5-membered aromatic ring)-amido anti-viral compounds | |
US2007032488A1 | 6-Membered aryl and heteroaryl derivatives for treating viruses | |
MY142331A | Bicyclic heteroaryl derivatives for treating viruses | |
MX2007016144A | Heteroaryl derivatives for treating viruses. | |
US2006241064A1 | Nucleoside compounds for treating viral infections | |
WO2007084157A2 | Nucleoside prodrugs for treating viral infections | |
WO2006102594A1 | Nucleoside prodrugs for treating viral infections | |
CN101142226A | Tricyclic-nucleoside prodrugs for treating viral infections | |
WO2006121468A1 | 5-nitro-nucleoside compounds for treating viral infections |